Clinical Trial Update: Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lupus immunosuppressive/immunomodulatory therapy or stem cell transplant has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: WITHDRAWN